% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@INBOOK{Worthoff:858923,
author = {Worthoff, Wieland and Mauler, J. and Oros-Peusquens, A. M.},
title = {{CHAPTER} 4. {U}ltra-high {F}ield {I}maging},
address = {Cambridge},
publisher = {Royal Society of Chemistry},
reportid = {FZJ-2018-07759},
series = {New Developments in NMR},
pages = {101 - 128},
year = {2018},
comment = {Hybrid MR-PET Imaging / Shah, N Jon (Editor)},
booktitle = {Hybrid MR-PET Imaging / Shah, N Jon
(Editor)},
abstract = {MR spectroscopy (MRS) reveals information about the
molecular structures underlying the MR signal. Properties
such as chemical shift and scalar coupling cause a
characteristic splitting of the resonance frequencies and
following the numerical fitting of the acquired data to the
corresponding basis spectra, these shifts can be used to
distinguish different kinds of molecules. For in vivo
applications, spatial localisation techniques for signal
acquisition, such as STEAM or PRESS, and water signal
suppression, i.e. CHESS or MEGA, are required. Using
non-proton nuclei as target nuclei allows MRI to investigate
in vivo metabolic processes and pathology non-invasively.
These so-called X-nuclei impose increased technological and
methodological demands, as the sensitivity and abundance are
significantly lower compared to protons and their spin
dynamics might be more sophisticated and complex.
Nevertheless, the potential benefit of acquiring such data
is tremendous both clinically and in research. The most
prominent X-nuclei in vivo are 2H, 7Li, 13C, 17O, 19F, 23Na,
31P, 35Cl and 39K and a subset are discussed here. One of
the applications that constitutes a ‘perfect fit’ for
ultra-high field imaging is the depiction of brain anatomy.
The usual challenges of ultra-high field imaging pertain but
once overcome anatomical imaging of the brain is able to
produce in vivo images with unprecedented resolution and
contrast. The chapter concludes with a brief excursion into
‘emerging applications’ and includes phase and
susceptibility imaging, quantitative susceptibility imaging
and CEST-based imaging at ultra-high field.},
cin = {INM-4 / INM-11 / JARA-BRAIN},
cid = {I:(DE-Juel1)INM-4-20090406 / I:(DE-Juel1)INM-11-20170113 /
$I:(DE-82)080010_20140620$},
pnm = {573 - Neuroimaging (POF3-573)},
pid = {G:(DE-HGF)POF3-573},
typ = {PUB:(DE-HGF)7},
doi = {10.1039/9781788013062-00101},
url = {https://juser.fz-juelich.de/record/858923},
}